Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
−Removed: Our common stock trades on the NYSE under the trading symbol “FET.” As of February 21, 2025, there were approximately 26 common stockholders of record.
+Added: Our common stock trades on the NYSE and NYSE Texas under the trading symbol “FET.” As of February 20, 2026, there were approximately 300 common stockholders of record.
In calculating the number of shareholders, we consider clearing agencies and security position listings as one shareholder for each agency or listing.
−Removed: No dividends were declared or issued during 2024 or 2023, and we do not currently have any plans to pay cash dividends in the future.
−Removed: Our future dividend policy is within the discretion of our board of directors and will depend upon various factors, including our results of operations, financial condition, capital requirements, investment opportunities, and restrictions under our loan agreements.
+Added: No dividends were declared or issued during 2025 or 2024, and we do not currently have any immediate plans to pay cash dividends in the future.
+Added: Our future dividend policy is within the discretion of our board of directors and would depend upon various factors, including our results of operations, financial condition, capital requirements, investment opportunities, and restrictions under our loan agreements.
Purchase of Equity Securities
3 unchanged sentences
The program may be executed using open market purchases pursuant to Rule 10b-18 under the Securities Exchange Act of 1934 (the “Exchange Act”), in privately negotiated agreements or by way of issuer tender offers, Rule 10b5-1 plans or other transactions.
−Removed: From the inception of the November 2021 Program through December 2024, we repurchased approximately 298 thousand shares of our common stock for aggregate consideration of $7.6 million.
−Removed: No shares were purchased during the three months ended December 31, 2024 under our November 2021 Program or our December 2024 Program.
−Removed: As of December 31, 2024, remaining authorization under the December 2024 Program is $75.0 million.
−Removed: Subsequent to December 31, 2024, we repurchased approximately 105 thousand shares of our common stock for aggregate consideration of $2.0 million.
+Added: From the inception of the programs in November 2021 through December 31, 2025, we repurchased approximately 1.7 million shares of our common stock for aggregate consideration of $41.9 million.
+Added: We repurchased approximately 1.4 million shares of our common stock for aggregate consideration of $34.3 million during 2025.
+Added: The following table is a summary of our repurchases of our common stock during the three months ended December 31, 2025.
+Added: As of December 31, 2025, the remaining authorization under the Repurchase Program is $40.7 million .
+Added: Period Total number of shares purchased Average price paid per share Total number of shares purchased as part of publicly announced plan or programs Maximum value of shares that may yet be purchased under the plan or program (in thousands)
+Added: October 1, 2025 - October 31, 2025 162,341 $ 27.69 162,341 $ 49,239
+Added: November 1, 2025 - November 30, 2025 96,306 $ 29.28 96,306 $ 46,419
+Added: December 1, 2025 - December 31, 2025 162,788 $ 35.19 162,788 $ 40,691
+Added: Total 421,435 $ 30.95 421,435
+Added: Subsequent to December 31, 2025 through February 20, 2026, we repurchased approximately 0.1 million shares of our common stock for aggregate consideration of $3.1 million.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.